insights_auto
Why is AXGN down 5.06%?
Dive Deeperchevron_right
AXGN:NASDAQ
AxoGen, Inc Common Stock
$48.75
arrow_downward
-5.06%(-2.60) 1D
$49.32
arrow_upward
+1.17% (+0.57)bedtimeAfter hours
Closed: Nov 5, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AXGN...
Open
$51.62
High
$51.85
Low
$47.57
Mkt. cap
2.91B
Avg. vol.
1.78M
Volume
1.21M
52-wk high
$52.91
52-wk low
$23.00
EPS
-$0.68
Beta
1.21
Shares outstanding
59.73M
No. of employees
622
Open
$51.62
High
$51.85
Low
$47.57
Mkt. cap
2.91B
Avg. vol.
1.78M
Volume
1.21M
52-wk high
$52.91
52-wk low
$23.00
EPS
-$0.68
Beta
1.21
Shares outstanding
59.73M
No. of employees
622
News stories
From web sources and news partners
Forbes
·
21 minutes ago
Hidden Risk In The SP 500: When Diversification Becomes An Illusion
marketscreener.com
·
10 minutes ago
Gold eases on inflation worries from higher oil; US payrolls data in focus
Chattanooga Times Free Press
·
25 minutes ago
A brutal sell-off for AI stocks sends Wall Street reeling, and the S&P 500 tumbles 4.4%
Nacionale
·
4 hours ago
What is the VIX? Wall Street's 'fear gauge' jumped about 70% as tech stocks sank
Profile
Axogen is a developer of surgical solutions, including human tissue grafts, based in Tampa, Florida. Axogen products are designed to remedy peripheral nerve damage. In 2013 the company raised $18 million in its initial public offering. Axogen uses a cell graft technology Avance to mimic a human nerve. The company also creates nerve connectors and soft tissue membranes. The company reports sensory and movement recovery in 87 percent of patients with peripheral nerve injuries. Axogen is part of the Sid Martin Biotechnology Incubator.
As of 2019, Axogen was the only commercially available nerve allograft approved by the Food and Drug Administration for clinical use. Wikipedia
About AxoGen, Inc Common Stock
CEO-
Employees622
Founded2002
HeadquartersAlachua, Florida, United States
SectorHealth Care
IndustryMedical device
Websiteaxogeninc.com